SARS News and Research

RSS

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Researchers investigate the duration of effectiveness of mRNA-based COVID-19 vaccines in preventing ICU admission.

21 Apr 2022

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Researchers isolate three mAbs that broadly neutralized sarbecoviruses and carried out virological and structural studies of these mAbs.

21 Apr 2022

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

A new study describes the impact of SARS-CoV-2 on host lipid metabolism.

21 Apr 2022

COVID-19 diagnosis in pregnancy and the postnatal period: Study

A new study provides new information on the impact of COVID-19 on pregnancy and postpartum outcomes.

21 Apr 2022

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

Do a person's antibodies work to block the COVID-19 virus from infecting one's system? Are these antibodies also capable of blocking emerging variants such as the omicrons?

21 Apr 2022

New approach successfully differentiates between antibodies against influenza and SARS-CoV-2

A new study shows that it is possible to use the genetic sequences of a person's antibodies to predict what pathogens those antibodies will target.

21 Apr 2022

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Researchers developed a clustered regularly interspaced short palindromic repeats-based diagnostic technique for detecting SARS-CoV-2 RNA.

21 Apr 2022

Physical and mental characteristics post-COVID-19 infection

Researchers conducted symptom assessment, cognitive tests, and physical measurements after COVID-19 infections.

21 Apr 2022

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Researchers investigated the interplay of all the factors responsible for within-host evolution of SARS-CoV-2 variants in immunocompromised patients.

21 Apr 2022

Association between SARS-CoV-2 Omicron viral load and vaccination history

Researchers analyzed the association between viral loads in SARS-CoV-2 Omicron variant infection and vaccination history.

21 Apr 2022

Evolution of SARS-CoV-2 variants

Research has demonstrated the evolutionary process and biology of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic.

21 Apr 2022

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers investigated the effect of binding antibodies on SARS-CoV-2 Omicron breakthrough infections.

21 Apr 2022

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

In a new study, risk assessments for research, survey, monitoring, management, wildlife rehabilitation, and wildlife control were updated regarding SARS-CoV-2.

21 Apr 2022

Study evaluates the use of a diagnostic code for Long COVID

Researchers evaluated the use of U09.9, a CD-10-CM code described as 'Post coronavirus disease 2019 (COVID-19) condition, unspecified' for post-acute COVID-19 sequelae (long COVID).

21 Apr 2022

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Researchers surveyed over 360 COVID-19 patients to characterize the SARS-CoV-2 genomic sequence diversity of individual infections.

21 Apr 2022

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice.

21 Apr 2022

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

A study released in JAMA Network Open by investigators at Providence, one of the largest health systems in the United States, and the University of Chicago, found that the level of protection granted by a prior symptomatic COVID-19 infection among unvaccinated individuals was on par with the level of protection provided by mRNA vaccines, with natural immunity providing a longer window of protection than mRNA vaccines.

20 Apr 2022

RNA splicing abnormalities in COVID-19 patients

This study entailed the integration of multiple-omics datasets to examine the dysregulation in the host splicing mechanism and alteration in protein isoforms among COVID-19 patients.

20 Apr 2022

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

A recent study has revealed a full cycle of substrate cleavage for the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – providing, in turn, a steadfast foundation for developing potent new viral inhibitors. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS).

20 Apr 2022

Study examines vitamin D and COVID-19 media coverage in the U.K.

A new study investigates the relationship between COVID-19 and vitamin D that has been presented in traditional media sources like U.K. newspapers.

20 Apr 2022

SARS News and Research

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

COVID-19 diagnosis in pregnancy and the postnatal period: Study

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

New approach successfully differentiates between antibodies against influenza and SARS-CoV-2

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Physical and mental characteristics post-COVID-19 infection

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Association between SARS-CoV-2 Omicron viral load and vaccination history

Evolution of SARS-CoV-2 variants

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

Study evaluates the use of a diagnostic code for Long COVID

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

RNA splicing abnormalities in COVID-19 patients

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

Study examines vitamin D and COVID-19 media coverage in the U.K.

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News